- Home
- KROS vs FJET Comparison
KROS vs FJET Comparison
Compare KROS & FJET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KROS | FJET |
|---|---|---|
| Founded | 2015 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Air Freight/Delivery Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 206.0M | 241.2M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | KROS | FJET |
|---|---|---|
| Price | $11.80 | $4.45 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $21.86 | N/A |
| AVG Volume (30 Days) | 318.8K | ★ 1.7M |
| Earning Date | 05-06-2026 | 04-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 146.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $243,864,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2,751.79 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.69 | $4.11 |
| 52 Week High | $22.55 | $28.56 |
Technical Indicators
Market Signals| Indicator | KROS | FJET |
|---|---|---|
| Relative Strength Index (RSI) | 58.11 | 38.55 |
| Support Level | $10.14 | N/A |
| Resistance Level | $12.43 | $5.88 |
| Average True Range (ATR) | 0.58 | 0.49 |
| MACD | 0.14 | -0.05 |
| Stochastic Oscillator | 70.03 | 20.81 |
Price Performance
Historical ComparisonAbout KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About FJET Starfighters Space Inc. Common Stock
Starfighters Space Inc is a commercial aerospace company based at NASA's Kennedy Space Center in Florida, with an additional base of operations at Midland International Air & Space Port in Texas, and has a fleet of seven F-104 Fighter jets that are capable of flying MACH 2+. Its activities include air launch operations, pilot and space flight training, support research, hypersonic testing, and other aerospace development programs. The company has one operating segment, which is principally the operations of F-104 Fighter jets and the development of infrastructure for orbital space launch.